standard care

vascuCAP®

• Over 70% improvement in stroke prediction accuracy over stenosis-based guidelines

​

• Over 30% improvement in MACE (heart attack) prediction accuracy over current standard of care

1

(2)

1. As presented at Society for Vascular Surgery conference 2020, "CRISP" trial interim results

2. “Automated plaque analysis for the prognostication of major adverse cardiac events” European Journal of Radiology

standard care

vascuCAP®

• $4,200 savings per Coronary Artery analysis

​

• $1,000 savings per Carotid Artery analysis​​

​

• Reimbursement for both workflows

(1) Potential after 1 year when compared to standard care for total health care system due to better outcomes, reduction in overtreatment, and increased provider efficiency

standard care

vascuCAP®

• Increased provider efficiency through easy-to-digest chart and narrative reports

​

• On-premise software analyzes in minutes

​​

• Better informed decision-making to improve patient outcomes

​

• Non-invasive procedure reduces patient burden & time spent in facility